TRIAZOLE DERIVATIVES FOR TREATMENT OF ALZHEIMER'S DISEASE

According to the invention there is provided a compound of formula I or a pharmaceutically acceptable salt or hydrate thereof; wherein the variables are as defined herein. The compounds selectively attenuate the production of A 42 and hence are useful in treatment of Alzheimer's disease and rel...

Full description

Saved in:
Bibliographic Details
Main Authors KATTAR SAM, ZHOU HUA, CHICHETTI STEPHANIE, SCHELL ADAM J, MUNOZ BENITO, METHOT JOEY, BROWN WILLIAM COLBY, AHEARN SEAN P, RIVKIN ALEXEY A, ROSENAU ANDREW, FISCHER CHRISTIAN, CHRISTOPHER MATTHEW, LI CHAOMIN, MACCOSS RACHEL N
Format Patent
LanguageEnglish
Published 26.01.2012
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:According to the invention there is provided a compound of formula I or a pharmaceutically acceptable salt or hydrate thereof; wherein the variables are as defined herein. The compounds selectively attenuate the production of A 42 and hence are useful in treatment of Alzheimer's disease and related conditions.
Bibliography:Application Number: US200913139830